This Constellation Brands Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Comments
Loading...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Goldman Sachs analyst Will Nance downgraded the rating for Flywire Corporation FLYW from Buy to Neutral and lowered the price target from $26 to $15. Flywire shares closed at $11.05 on Wednesday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Arthur He downgraded LAVA Therapeutics N.V. LVTX from Buy to Neutral and lowered the price target from $2 to $1.5. LAVA Therapeutics shares closed at $1.35 on Wednesday. See how other analysts view this stock.
  • JP Morgan analyst Jeffrey Zekauskas downgraded the rating for Olin Corporation OLN from Overweight to Neutral and lowered the price target from $50 to $28. Olin shares closed at $25.79 on Wednesday. See how other analysts view this stock.
  • Barclays analyst Nicholas Campanella downgraded Sempra SRE from Overweight to Equal-Weight and lowered the price target from $95 to $72. Sempra shares closed at $72.85 on Wednesday. See how other analysts view this stock.
  • Morgan Stanley analyst Dara Mohsenian downgraded the rating for Constellation Brands, Inc. STZ from Overweight to Equal-Weight and lowered the price target from $220 to $202. Constellation shares closed at $178.35 on Wednesday. See how other analysts view this stock.

Read This Next:

FLYW Logo
FLYWFlywire Corp
$8.671.64%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
8.46
Growth
82.29
Quality
-
Value
15.90
Price Trend
Short
Medium
Long
Got Questions? Ask
Which healthcare stocks could benefit from LAVA's downgrade?
How will Flywire's downgrade affect fintech investments?
Which chemicals sector stocks might be undervalued after Olin's downgrade?
Could energy companies see shifts after Sempra's rating change?
How might beer industry stocks react to Constellation's downgrade?
Are there emerging markets benefitting from Constellation's challenges?
Which analyst downgrades might present buying opportunities?
Could retail investors capitalize on these downgrades?
What market trends could impact the companies downgraded?
How might investors adjust portfolios post-downgrades?
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In: